Taking a Patient-Centric Approach to Mobile and Patient-Facing Technologies in Clinical Trials

Patrick Floody, MBA, is the Head of the Global Clinical Trial Services group at Regeneron where he is responsible for global site management, central monitoring, study feasibility and site selection, study/site start up, eCOA and patient technology initiatives. He has been with Regeneron for just over 3 years.Mr Floody spent 25 years at Pfizer, with most of his time spent in clinical program operations but also included time in GCP Quality (level 1) and Analytics. He has extensive international experience in drug development and helped establish the Pfizer country office development teams in Latin America, India and other parts of Asia. Subsequently, he spent 10 years in Pfizer’s Development Japan organization as Head of Japan Development Operations and Development Japan Portfolio & Project Management Groups. He was the recipient of Pfizer’s PGRD Achievement Award in 2007.Mr Floody is a former officer in the U.S. Army and is a veteran of the first Gulf War. He holds a bachelor’s degree in Biology from the University of Rhode Island and a Master of Business Administration from Temple University.